Stifel Financial Corp Jounce Therapeutics, Inc. Transaction History

Stifel Financial Corp

  • $93.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$6.01 - $8.54 $152,497 - $216,693
-25,374 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$7.11 - $9.64 $180,409 - $244,605
25,374 New
25,374 $212,000
Q1 2020

May 14, 2020
SELL
$2.91 - $8.7 $43,114 - $128,899
-14,816 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$2.81 - $9.21 $41,632 - $136,455
14,816 New
14,816 $131,000

Others Institutions Holding JNCE

# of Institutions
4
Shares Held
720K
Call Options Held
0
Put Options Held
0
View Full List

About Jounce Therapeutics, Inc.

JNCE Quotes by TradingView
  • Ticker JNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,694,200
  • Description
  • Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...
More about JNCE
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email